S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
Conditions: Prevention & Control; Diarrhea Caused by Drug; Respiratory Infection Bacterial; Anti-Bacterial Agents Intervention: Drug: drug product: capsules are containing S. boulardii, administered twice daily (250 mg) Sponsors: Clinical Centre of Serbia; Institute for Pulmonary Diseases of Vojvodina Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2022 Category: Research Source Type: clinical trials